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Many US adults have multiple chronic conditions, and hyperten-
sion and diabetes are among the most common dyads. Diabetes
and prediabetes prevalence are increasing, and both conditions
negatively affect cardiovascular health. Early diagnosis and treat-
ment of diabetes and prediabetes can benefit people with hyperten-
sion by preventing cardiovascular complications.
Methods
We analyzed 2011 Minnesota Behavioral  Risk Factor Surveil-
lance System data to describe the proportion of adults with hyper-
tension screened for diabetes according to US Preventive Services
Task Force Recommendations for blood glucose testing. Covari-
ates associated with lower odds of recent screening among adults
without diabetes were determined using weighted logistic regres-
sion.
Results
Of Minnesota adults with self-reported hypertension, 19.6% had a
diagnosis of diabetes and 10.7% had a diagnosis of prediabetes.
Nearly one-third of adults with hypertension without diabetes had
not received blood glucose screening in the past 3 years. Factors
associated with greater odds of not being screened in multivari-
able models included being aged 18 to 44 years (adjusted odds ra-
tio [AOR], 1.77; 95% confidence interval [CI], 1.23–2.55); being
nonobese, with stronger effects for normal body mass index; hav-
ing  no  check-up  in  the  past  2  years  (AOR,  2.49;  95%  CI,
1.49–4.17); having hypertension treated with medication (AOR,
2.01; 95% CI, 1.49–2.71); and completing less than a college de-
gree (AOR, 1.45; 95% CI, 1.14–1.84). Excluding respondents with
prediabetes or those not receiving a check-up did not change the
results.
Conclusions
Failure to screen among providers and failure to understand the
importance of screening among individuals with hypertension may
mean missed opportunities for early detection, clinical manage-
ment, and prevention of diabetes.
Introduction
In 2010, 26% of US adults lived with 2 or more chronic condi-
tions  (1),  a  number  expected  to  increase  as  the  prevalence  of
chronic conditions increases (2).  The most common pairing of
multiple chronic conditions across ages is diabetes and hyperten-
sion  (1).  In  Minnesota,  the  adult  diabetes  prevalence  nearly
doubled in the past 15 years to more than 7%, and 26% of adults
report receiving a hypertension diagnosis (3,4).
Recent evidence-based guidelines for prevention of diabetes and
cardiovascular risk emphasize expanded delivery of preventive
clinical services, which may improve referral to diabetes preven-
tion programs and early clinical management for adults with dia-
betes (5,6). Blood pressure control among adults with diabetes sig-
nificantly reduces cardiovascular events (7,8).  On the basis of
blood pressure data, the US Preventive Services Task Force (USP-
STF) rated blood glucose screening for people with diagnosed hy-
pertension a Grade B recommendation, making it a covered pre-
ventive service under the Affordable Care Act (9).
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Despite the value of diabetes screening in patients with hyperten-
sion,  estimates  of  the  implementation  of  USPSTF  screening
guidelines are unavailable. National Health and Nutrition Examin-
ation  Survey  (NHANES)  data  from  2005–2006  indicate  that
53.2% of adults with hypertension have been screened (10); re-
cent analyses were limited to attributes of different screening cri-
teria, including sensitivity, specificity, and absolute numbers of
cases detected (11,12). Assessment of screening rates and patient-
level characteristics associated with screening status are needed.
This analysis describes blood glucose screening rates and patient-
level characteristics among Minnesota adults with hypertension.
The results provide baseline information for developing public
health and clinical strategies to identify patients with hypertension
who are at risk for diabetes.
Methods
To assess blood glucose screening rates, we obtained data for Min-
nesota from the 2011 Behavioral Risk Factor Surveillance System
(BRFSS) (13), a state-based survey of health-related behaviors
among noninstitutionalized US adults aged 18 years or older and
administered by states for the Centers for Disease Control and Pre-
vention (CDC). Standardized clinical measures assessing diabetes
management do exist, but standardized clinical measures for as-
sessing diabetes screening rates do not exist. BRFSS provides a
unique opportunity to assess statewide trends.
We limited analysis to 2011 data because differences in sampling
and weighting initiated for the 2011 survey make results noncom-
parable to those of previous years. In Minnesota, the percentage of
people with complete or partially complete interviews (ie, cooper-
ation rate), was 82.2%, and the completion rate was 51.9%, high-
er  than  the  national  medians  of  73.8% (cooperation  rate)  and
49.7% (completion rate)  (14).  We identified  a  cross-sectional
sample  of  adults  (N = 3,847)  with  self-reported hypertension,
available  covariate  data,  self-reported  diabetes  or  prediabetes
status, and blood glucose screening in the previous 3 years.
We identified all people with hypertension and then determined
subsets of people who would closely meet the definition of asymp-
tomatic for diabetes used in the USPSTF recommendation (Fig-
ure). All responses of “don’t know/not sure” or “refused” were
treated as missing.
Figure.  Flow  diagram  describing  cohort  with  hypertension  (N  =  3,847),
classified according to diabetes status, prediabetes status, and self-reported
blood glucose screening for diabetes in the last 3 years, Minnesota Behavioral
Risk Factor Surveillance System (BRFSS), 2011. Abbreviations: BMI, body
mass index; screened, self-reported blood glucose screening.
 
Diagnoses and screening
Respondents  were asked a series  of  questions relating to high
blood pressure and diabetes (15). All adults who responded yes to
the question, “Have you ever been told by a doctor, nurse, or oth-
er health professional that you have high blood pressure?” were
considered to have hypertension. Similar to the procedure used by
Kilmer et al (16), we assigned a composite variable for diabetes,
prediabetes, and screening. Diabetes status was ascertained by ask-
ing people whether a “doctor, nurse, or other health professional
ever told you that you . . . have diabetes?” Women who respon-
ded yes were asked, “Was this only when you were pregnant?” If
they had diabetes only when pregnant, they were considered not to
have diabetes.  For all  other yes responses, the respondent was
classified as having diabetes. Adults with hypertension not classi-
fied as having diabetes were asked, “Have you ever been told by a
doctor or other health professional that you have prediabetes or
borderline diabetes?” Women were asked “Was this only when
you were pregnant?” If women responded yes, they were coded as
not having prediabetes. All others who responded affirmatively
were coded as having prediabetes. All adults with hypertension
were classified as having self-reported diabetes, self-reported pre-
diabetes, or neither.
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To assess screening among adults with hypertension but no dia-
betes diagnosis, these adults were asked, “Have you had a test for
high blood sugar or diabetes within the past 3 years?” Yes and no
responses classified individuals as screened and not screened, re-
spectively (15).
We used the diagnosis-screening variable to create 4 groups: 1)
self-reported diabetes diagnosis; 2) self-reported prediabetes dia-
gnosis; 3) no self-reported diabetes or prediabetes diagnosis and
self-reported glucose screening in the past 3 years; 4) no self-re-
ported diabetes or prediabetes diagnosis and no self-reported gluc-
ose screening in the past 3 years (Figure).
Covariates
Covariates were included because they are risk factors for hyper-
tension or diabetes (12), are associated with health literacy, may
be associated with access to care, and are associated with patterns
of  medical  care  use  and  disease  severity.  Variables  were  age
(18–44, 45–64, or ≥65 years), sex (male or female), race/ethnicity
(non-Hispanic white or other), education (collapsed into college
graduate or not), smoking (collapsed into current or not). Body
mass index (BMI, calculated by using self-reported height and
weight [kg/m2]) was classified as low/normal (<25.0), overweight
(25.0–29.9) and obese (≥30.0). Respondents with hypertension
were classified by whether they were taking medication to control
their hypertension. Health insurance status over the last year was
classified as yes or no. Check-up was defined as “a general phys-
ical exam, not an exam for a specific injury, illness, or condition”
(15), and the responses were either yes or no. Two years was se-
lected as the time frame for the last check-up, because it  most
closely aligns with the 3-year glucose screening interval.
Analysis
Analyses were conducted by using SAS 9.2 (SAS Institute, Inc)
and survey procedures to incorporate sampling weights into the
analysis. Symmetric 95% confidence intervals (CIs) were calcu-
lated for frequencies. Differences between proportions were tested
by using a Rao-Scott χ2 test. All results were weighted to adjust
for nonresponse rates and probability of selection into the survey.
Missing data were treated as not-missing-at-random to be more
conservative with estimates of standard error.
Proc SurveyFreq was used to calculate frequencies for all adults
with diagnosed hypertension and the subset who did not report
diabetes. Additionally, frequencies were generated using proced-
ures similar to those used by Kilmer et al (16) to understand rela-
tions between demographic, lifestyle, or health care access vari-
ables and the spectrum of glycemic states among adults with hy-
pertension, because the proportion of adults with diagnosed dia-
betes also influences the proportion of adults with hypertension
who were eligible for screening and other presented results. Sens-
itivity analyses were conducted to examine whether patterns were
influenced  by  people  with  coronary  heart  disease  (CHD).  As
Kilmer et al did (16), we removed adults with hypertension who
had CHD according to survey questions about history of myocar-
dial infarction, angina, and coronary heart disease. Differences in
the distribution of diabetes and prediabetes diagnosis or screening
across levels of each covariate were tested by using a Rao-Scott χ2
test.
We used logistic regression to determine associations (odds ratios
[ORs]) between demographic, lifestyle,  and health care access
variables and blood glucose screening in the past 3 years. Univari-
ate associations were determined for all covariates for the sample
and all  respondents with hypertension who had available data.
Results did not differ. A multivariable model included all poten-
tial covariates to determine the effect of each covariate after con-
trolling for all others in the model. A model including all signific-
ant covariates (P < .05) is presented. We tested models that in-
cluded an interaction term between age and BMI and found the in-
teraction term to be nonsignificant. Three sensitivity analyses were
conducted: 1 model limiting analyses to respondents who had had
a check-up within the past 2 years, on the assumption that this vis-
it provided an opportunity for preventive efforts like blood gluc-
ose screening; 1 limited to non-Hispanic whites, because the small
number of respondents from other racial/ethnic groups prevented
analysis by race/ethnicity or adjustment; and 1 excluding respond-
ents who had diagnosed prediabetes, because clinical guidelines
recommend annual blood glucose monitoring (17), increasing the
probability  of  screening.  Among individuals  with prediabetes,
90% reported having had a blood glucose test in the past 3 years.
Results
Weighted frequencies were used to describe Minnesota adults with
diagnosed hypertension (Table 1). Most were 45 years or older
(81%) and non-Hispanic white (90%); there were slightly more
men than women in this group. Nearly 80% were classified as
either  overweight  or  obese.  Approximately  22% were  college
graduates.  More  than  90% had  insurance  coverage  and  had  a
check-up in the past 2 years. Less than 1 in 7 reported coronary
heart disease, and 20% reported a diagnosis of diabetes. Character-
istics were not appreciably different for the subset of individuals
with hypertension who had no diabetes diagnosis (Table 1), and
67.6% of these adults reported blood glucose testing within the
past 3 years.
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Other descriptive analysis focused on 4 groups of people with hy-
pertension:  those diagnosed with  diabetes  (19.6%),  those dia-
gnosed with prediabetes (10.7%), those diagnosed with neither
diabetes nor prediabetes and screened in the past 3 years (no dia-
gnosis, screened, 44.6%), and those diagnosed with neither dia-
betes nor prediabetes but not screened in the past 3 years (no dia-
gnosis, unscreened, 25.1%) (Table 2). We examined the propor-
tion of adults in each composite diagnosis-screening group strati-
fied by diabetes risk factors and access to the health care system
(Table 2).  The percentage of adults with diabetes tended to be
higher among adults who were obese, had lower educational at-
tainment, were of a race/ethnicity other than non-Hispanic white,
and not current smokers. Compared with their counterparts, the
percentage of adults who had no diagnosis and were unscreened
was greater  among adults  who were younger,  had lower BMI,
were current smokers, were not enrolled in a health plan, and did
not have a recent check-up. We also conducted analyses exclud-
ing the 14.6% of adults who had coronary heart disease; associ-
ations were unchanged.
To describe  associations  between  demographic,  lifestyle,  and
health care access and use variables and screening among respond-
ents at risk of developing diabetes, we calculated the odds of not
being tested within the past 3 years (Table 3). Adults aged 18 to
44  were  2.64  (95%  CI,  1.89–3.67)  times  as  likely  to  not  be
screened compared with adults aged 65 years or older; there was
no meaningful difference for adults aged 45 to 64 versus those
aged 65 years or older. Odds of not being screened were elevated
for adults with low/normal BMI compared with those who were
obese, for those without a college degree compared with those
with a college degree, and for current smokers compared with nev-
er smokers. Adults not taking medication to manage their hyper-
tension  were  less  likely  to  be  screened  (OR,  2.94;  95%  CI,
2.25–3.85) than those who did take medication. Nonenrollment in
a health plan (OR, 1.97; 95% CI, 1.22–3.17) and lack of a check-
up in the past 2 years (OR, 3.70; 95% CI, 2.28–6.02) were associ-
ated with not being screened. In multivariable models, most asso-
ciations remained, with similar magnitude of effect. Smoking was
no longer associated with screening, nor was health plan enroll-
ment. Removing covariates that were significant at P < .05 did not
appreciably change the overall results or point estimates of associ-
ations between covariates and no screening. None of the 3 sensit-
ivity analyses changed results appreciably. For example, in data
limited to non-Hispanic whites  only,  associations between re-
spondents aged 18 to 44 years (OR, 1.90; 95% CI, 1.28–2.81) and
not  having  a  check-up  (OR,  3.08;  95%  CI,  1.93–4.91)  were
strengthened slightly. If limited to respondents without a predia-
betes diagnosis, the association with not having a check-up was
strengthened (OR, 3.10; 95% CI, 1.83–5.24).
Discussion
Nearly  one-third  of  Minnesota  adults  who  have  hypertension
without a diabetes diagnosis reported not receiving recommended
blood glucose screening in the past 3 years. Adults with hyperten-
sion are a group at high risk for developing diabetes; 19.6% and
10.7% of Minnesota adults with hypertension have diagnoses of
diabetes and prediabetes, respectively. Because 26% (or approx-
imately 1.1 million) of Minnesota adults report having a hyperten-
sion diagnosis (3), approximately 345,000 Minnesota adults with
hypertension would report not having recommended blood gluc-
ose screening. This is the first state or national assessment of USP-
STF diabetes screening rates that also identifies subpopulations
less frequently screened. Other state-based analyses of blood gluc-
ose screening using BRFSS data described rates in the general
adult population or a subset of obese adults that do not align with
national guidelines (18–20). Standardized clinical measures for
diabetes screening for large population subgroups do not exist and
use of All Payer Claims Databases is in its infancy (21). BRFSS
provides a unique opportunity to assess statewide trends and mon-
itor the progress of programmatic strategies to improve diabetes
screening and hypertension management.
Use of self-reported data adds complexity to data interpretation
but does not make the effort less meaningful. Failure to report
screening  in  the  past  3  years  could  reflect  not  having  been
screened,  lack of  awareness  that  screening was needed or  oc-
curred, or both. Lack of awareness could be a function of low
health literacy (22,23) and could be used to guide programmatic
activity and intervention development.
Consistent with the concept of variable health literacy (22) among
adults with hypertension is the association between education and
blood glucose screening. Compared with adults with a college de-
gree, adults with less than a college degree were approximately
40% more likely not to have blood glucose testing, as has been ob-
served for people with CHD (16). Higher educational attainment
has been associated with greater agreement between self-report of
health conditions and the medical record (24).
Health systems factors may influence self-reported screening rates.
Not receiving a check-up was associated with lower self-reported
screening. Lack of health insurance showed the same relationship
in crude models but was not significant after adjustment, likely be-
cause of not having had a check-up. In Minnesota, more than 80%
of adults with diagnosed hypertension reported visiting a provider
in the last year, whereas the US average is 70% (12). Adults who
did not use medication to manage their hypertension were less
likely to be screened, consistent with results showing that adults
who take medication for hypertension or hypercholesterolemia
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were more aware of their prediabetes status (25). Additional visits
for medication management may be required, providing more op-
portunities for screening; conversely, enhanced screening may re-
flect clinical assessment of this subgroup being at higher risk.
Variation in screening rates by BMI and age suggest that provider
or health systems strategies may also be warranted. After adjust-
ment for other factors, adults younger than 45 years and those with
low/normal and overweight BMI were less likely to report screen-
ing, as reported previously for adults with CHD (16). The results
suggest that providers do not screen all people with hypertension
with equal probability,  and providers may screen according to
guidelines that take age and BMI into account (ie, guidelines from
the American Diabetes Association [ADA] or National Institute of
Diabetes and Digestive and Kidney Diseases [NIDDK]) (17,26).
The results also suggest that awareness of diabetes risk and the
need for screening is lower among these groups (ie, adults young-
er than 45 years and adults with lower BMI) and they are less
likely to recall provider-ordered testing. Screening rates among
Minnesota adults aged 45 years or older show BMI-related pat-
terns consistent with NIDDK guidelines; in 2011, 63% of over-
weight or obese adults and 52.1% with low/normal BMI reported
screening. NIDDK recommends screening for overweight or obese
adults aged 45 years or older and that testing be considered for
normal-weight adults of the same age (26). ADA recommends
screening all adults aged 45 years or older (17). Given these mul-
tiple guidelines, there may be lack of clarity regarding popula-
tions eligible for screening.
Strategies addressing barriers related to providers, health systems,
and health literacy may improve blood glucose screening rates
among adults with hypertension in Minnesota. To address pro-
vider awareness and screening, several approaches can be con-
sidered: 1) analyzing screening rates using electronic health re-
cord data  or  assessing All-Payer  Claims Databases’  provider-
ordered screening rates (21), 2) emphasizing that screening adults
with  hypertension  is  largely  consistent  with  other  screening
guidelines, and 3) using clinical decision tools or including blood
glucose  screening  in  hypertension  management  plans.  Recent
policy changes also may improve access to care. The Affordable
Care Act expands the number of people insured and provides an
annual preventive visit that could address blood glucose screening
at no cost to the patient. Efforts to address health literacy could in-
clude awareness campaigns that emphasize the need for blood
glucose screening for all adults with hypertension and stress that
preventive visits, now a covered benefit under the Affordable Care
Act, are opportunities for recommended screening.
Although our analysis is meant to inform programmatic efforts in
Minnesota, our findings may be useful more broadly. National-
level analysis of diabetes screening rates among adults with CHD
found similar rates and screening patterns. Blood glucose screen-
ing rates from the 16 states with available 2011 BRFSS blood
glucose screening data for all  adults with hypertension ranged
from 61.9% to 74.1% . Minnesota rates fall midrange, failing to
provide evidence that our rates would be highly divergent from
results in other states. Univariate analysis of blood glucose screen-
ing rates for all adults in Montana (BRFSS 2009) and New York
(BRFSS 2008–2009) demonstrated lower screening rates  with
lower BMI, lower age, and lower educational attainment, consist-
ent with our findings (18,19).
Our study has 5 key limitations. First, we were unable to identify
asymptomatic adults with hypertension, the population to which
the USPSTF recommendation applies (9), because BRFSS lacks
questions  about  signs  and symptoms of  diabetes  among those
without  a  diagnosis.  Second,  self-reported  measures  like  dia-
gnosed hypertension are a combination of testing and diagnosis
rates and awareness of the diagnosis. Third, the reliability of hy-
pertension and diabetes diagnoses and blood glucose screening is
not well-defined. Earlier work suggests high sensitivity for hyper-
tension, moderate sensitivity for diabetes, and high specificity for
both (27) (κ, range, 0.7–0.8, for both) (24). Reliability is import-
ant from a clinical perspective but becomes less so when address-
ing issues of patient awareness and health literacy. Fourth, small
numbers  limited  our  ability  to  examine  patterns  of  screening
among adults of nonwhite, non-Hispanic race/ethnicity. Finally,
we analyzed only 1 year of data. It is unlikely that using a single
year  of  data  misrepresents  larger  trends,  given  the  similarity
between 2011 BRFSS estimates in Minnesota and other states.
Also, the 19.6% prevalence rate for diabetes among Minnesota
adults with hypertension is similar to the rate of 18% to 18.5% re-
ported in 2005–2010 NHANES (28).
Nearly one-third of Minnesota adults with hypertension without
diabetes did not report having had blood glucose testing in the past
3 years, as recommended by the USPSTF. Failure to screen and
failure  to  understand  the  importance  of  screening  may  mean
missed opportunities for 1) early detection and good clinical man-
agement of diabetes and 2) identification of adults with predia-
betes and referral to evidence-based interventions that delay or
prevent the onset of diabetes (5,6,29) and that may confer addi-
tional cardiovascular benefit (30–32). Efforts to improve screen-
ing rates should consider a multifaceted approach, addressing pro-
vider-, health systems–, and health literacy-related barriers sugges-
ted by surveillance data.
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Tables
Table 1. Demographics and Health-Related Conditions Among Minnesota Adults With Self-Reported Hypertension, Behavioral Risk
Factor Surveillance System, 2011
Variable
Self-Reported Hypertension Diagnosis and
Complete Covariates (N = 3,847)
Self-Reported Hypertension Diagnosis and
Complete Covariates, Excluding Those with
Diabetes Diagnosis (N = 3,049)
N Weighted % (95% CI) N Weighted % (95% CI)
Age, y
18–44 416 19.0 (16.8–21.2) 374 21.3 (18.7–23.9)
45–64 1,690 42.5 (40.3–44.7) 1,352 41.9 (39.4–44.4)
≥65 1,741 38.5 (36.4–40.6) 1,323 36.9 (34.5–39.2)
Sex
Male 1,803 54.2 (51.9–56.4) 1,402 53.6 (51.1–56.1)
Female 2,044 45.8 (43.6–48.1) 1,647 46.4 (43.9–48.9)
Body mass index category (kg/m2)
Low/normal (<25.0) 866 21.4 (19.6–23.2) 775 23.7 (21.6–25.8)
Overweight (25.0–29.9) 1,482 38.3 (36.2–40.5) 1,226 39.7 (37.3–42.2)
Obese (≥30) 1,499 40.3 (38.0–42.5) 1,048 36.5 (34.0–39.1)
Education
Less than high school 244 11.9 (10.1–13.7) 168 10.7 (8.7–12.6)
High school graduate 1,210 33.5 (31.3–35.6) 924 32.8 (30.5–35.2)
Attend college/trade school 1,169 32.4 (30.3–34.6) 930 33.5 (31.0–35.9)
College graduate 1,224 22.3 (20.6–23.8) 1,027 23.0 (21.2–24.9)
Race/ethnicity
Not-Hispanic white 3,538 89.8 (88.2–91.4) 2,838 90.7 (88.9–92.5)
Other 309 10.2 (8.5–11.8) 211 9.3 (7.5–11.1)
Enrolled in a health plan
Yes 3,622 92.1 (90.5–93.7) 2,867 92.0 (90.3–93.8)
No 225 7.9 (6.3–9.5) 182 8.0 (6.2–9.7)
Had a check-up in the past 2 years
Yes 3,617 92.1 (90.5–93.6) 2,852 91.7 (89.9–93.4)
No 230 7.9 (6.4–9.5) 197 8.3 (6.6–10.1)
Smoking history
Current 562 17.8 (15.8–19.8) 461 19.1 (16.7–21.5)
Former 1,531 38.1 (36.0–40.3) 1,194 37.3 (34.8–39.7)
Never 1,754 44.0 (41.8–46.3) 1,394 43.6 (41.2–46.1)
Ever had a heart attack
Abbreviations: CI, confidence interval; NA, not applicable.
a A dash ( — ) indicates below reporting threshold of n = 50 needed to generate reliable frequencies.
(continued on next page)
PREVENTING CHRONIC DISEASE VOLUME 11, E207
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY   NOVEMBER 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
8       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2014/14_0204.htm
(continued)
Table 1. Demographics and Health-Related Conditions Among Minnesota Adults With Self-Reported Hypertension, Behavioral Risk
Factor Surveillance System, 2011
Variable
Self-Reported Hypertension Diagnosis and
Complete Covariates (N = 3,847)
Self-Reported Hypertension Diagnosis and
Complete Covariates, Excluding Those with
Diabetes Diagnosis (N = 3,049)
N Weighted % (95% CI) N Weighted % (95% CI)
Yes 370 10.0 (8.6–11.4) 247 8.3 (6.8–9.7)
No 3,453 90.0 (88.6–91.4) 2,787 91.3 (89.8–92.8)
Missing 24  —a 15  —a
Ever had angina or coronary heart disease diagnosis
Yes 383 9.2 (8.0–10.5) 246 7.3 (6.1–8.6)
No 3,431 90.8 (89.5–92.0) 2,784 92.0 (90.7–93.3)
Missing 33  —a 19 —a
Total coronary heart disease diagnosis
Yes 566 14.6 (13.0–16.2) 377 12.2 (10.5–13.8)
No 3,251 85.4 (83.8–87.0) 2,650 87.1 (85.5–88.8)
Missing 30  —a 22  —a
Taking hypertension medication
Yes 3,181 77.5 (75.4–79.7) 2,442 74.2 (71.6–76.7)
No 666 22.5 (20.3–24.6) 607 25.8 (23.3–28.4)
Diagnosis
Diabetes diagnosis 798 19.6 (17.9–21.3) 0 0
Prediabetes diagnosis 449 10.7 (9.3–12.0) 449 13.3 (11.6–14.9)
Neither 2,600 69.7 (67.7–71.8) 2,600 86.7 (85.0–88.4)
Blood glucose testing in past 3 years (among those without diabetes)
Yes 2,140 67.6 (65.1–70.0) 2,140 67.6 (65.1–70.0)
No 909 32.4 (30.0–34.9) 909 32.4 (30.0–34.9)
Excluded people with diabetes 798 NA NA
Abbreviations: CI, confidence interval; NA, not applicable.
a A dash ( — ) indicates below reporting threshold of n = 50 needed to generate reliable frequencies.
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Table 2. Blood Glucose Screening Results Among Adults With Hypertension in Minnesota, by Demographic, Lifestyle, and Health
Care Access Variables, Behavioral Risk Factor Surveillance System, 2011
Variable
Diabetes Prediabetes Neither, Screened Neither, Unscreened
P Value
N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)
Overall 798 19.6
(17.9–21.3)







































<.001Overweight (25.0–29.9) 256 16.6(14.0–19.3)




Obese (≥30) 451 27.0
(24.0–30.1)














College graduate 197 16.6
(13.7–19.5)





Non-Hispanic white 700 18.8
(17.1–20.5)































Enrolled in health plan
Abbreviations: CI, confidence interval; BMI, body mass index.
a A dash ( — ) indicates below reporting threshold of n = 50 needed to generate reliable frequencies
(continued on next page)
PREVENTING CHRONIC DISEASE VOLUME 11, E207
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY   NOVEMBER 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
10       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2014/14_0204.htm
(continued)
Table 2. Blood Glucose Screening Results Among Adults With Hypertension in Minnesota, by Demographic, Lifestyle, and Health
Care Access Variables, Behavioral Risk Factor Surveillance System, 2011
Variable
Diabetes Prediabetes Neither, Screened Neither, Unscreened
P Value
N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)
Yes 755 19.7
(17.9–21.4)









Had a check-up in the past 2 years
Yes 765 20.0
(18.2–21.7)























Abbreviations: CI, confidence interval; BMI, body mass index.
a A dash ( — ) indicates below reporting threshold of n = 50 needed to generate reliable frequencies
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Table 3. Odds of Not Having a Blood Glucose Test in the Last 3 Years Among Minnesota Adults with Hypertension and No Diabetes






OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Age, y
18–44 2.64 (1.89–3.67) <.001 1.83 (1.26–2.67) .002 1.77 (1.23–2.55) .002
45–64 1.07 (0.85–1.34) .57 1.01 (0.78–1.31) .92 1.02 (0.79–1.30) .91
≥65 1 [Reference]
Sex
Male 1.10 (0.90–1.39) .36 1.10 (0.87–1.39) .44 —
Female 1 [Reference] —
BMI category (kg/m2)
Low/normal (<25) 1.78 (1.32–2.39) <.001 2.24 (1.64–3.06) <.001 2.18 (1.60–2.96) <.001
Overweight (25–29.9) 1.25 (0.95–1.64) .12 1.43 (1.08–1.89) .01 1.44 (1.08–1.90) .01




1.41 (1.12–1.77) .004 1.50 (1.17–1.92) .001 1.45 (1.14–1.84) .003
College graduate 1 [Reference]
Race/ethnicity
Non-Hispanic white 1 [Reference]  —
Other 0.99 (0.64–1.52) .95 0.62 (0.37–1.05) .08  —
Smoking history
Current 1.47 (1.05–2.07) .03 0.83 (0.59–1.18) .30  —
Former 0.86 (0.68–1.08) .20 0.84 (0.65–1.07) .15  —
Never 1 [Reference]  —
Enrolled in health plan
Yes 1 [Reference]  —
No 1.97 (1.22–3.17) .006 1.15 (0.67–1.96) .62  —
Had a check-up in the last 2 Years
Yes 1 [Reference]
No 3.70 (2.28–6.02) <.001 2.56 (1.56–4.20) <.001 2.49 (1.49–4.17) <.001
Taking hypertensive medication
Yes 1 [Reference]
No 2.94 (2.25–3.85) <.001 2.05 (1.52–2.78) <.001 2.01 (1.49–2.71) <.001
Abbreviations: OR, odds ratio; CI, confidence interval; —, variable was not included in model; BMI, body mass index.
a The multivariable model includes all covariates; the full model includes only variables that were significant at P < .05.
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